Abstract
Mutations in 12 different PEX genes can cause a generalized peroxisomal biogenesis disorder with clinical phenotypes ranging from Zellweger syndrome to infantile Refsum disease. To identify the specific PEX gene to be sequenced, complementation analysis is first performed in fibroblasts using catalase immunofluorescence. A patient with a relatively mild phenotype of infantile cholestasis, hypotonia and motor delay had elevated plasma very long-chain fatty acids and bile acid precursors, but fibroblast studies revealed normal or only mildly abnormal peroxisomal parameters and mosaic catalase immunofluorescence. This mosaicism persisted even when the incubation temperature was increased from 37 °C to 40 °C, a maneuver previously shown to abolish mosaicism by exacerbating peroxisomal dysfunction. As mosaicism precludes complementation analysis, a candidate gene approach was employed. After PEX1 sequencing was unrewarding, PEX12 sequencing revealed homozygosity for a novel c.102A>T (p.R34S) missense mutation affecting a partially conserved residue in the N-terminal region important for localization to peroxisomes. Transfection of patient fibroblasts with wild-type PEX12 cDNA confirmed that a PEX12 defect was the basis for the PBD. Homozygosity for c.102A>T was identified in a second patient of similar ethnic origin also presenting with a mild phenotype. PEX12 is a highly probable candidate gene for direct sequencing in the context of a mild clinical phenotype with mosaicism and minimally abnormal peroxisomal parameters in fibroblasts.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chang CC, Gould SJ (1998) Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am J Hum Genet 63:1294–1306
Chang CC, Warren DS, Sacksteder KA, Gould SJ (1999) PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J Cell Biol 147:761–774
Gartner J, Preuss N, Brosius U, Biermanns M (1999) Mutations in PEX1 in peroxisome biogenesis disorders: G843D and a mild clinical phenotype. J Inherit Metab Dis 22:311–313
Gootjes J, Mooijer PA, Dekker C, Barth PG, Poll-The BT, Waterham HR, Wanders RJ (2002) Biochemical markers predicting survival in peroxisome biogenesis disorders. Neurology 59:1746–1749
Gootjes J, Schmohl F, Mooijer PA, Dekker C, Mandel H, Topcu M, Huemer M, Von Schutz M, Marquardt T, Smeitink JA, Waterham HR, Wanders RJ (2004a) Identification of the molecular defect in patients with peroxisomal mosaicism using a novel method involving culturing of cells at 40°C: implications for other inborn errors of metabolism. Hum Mutat 24:130–139
Gootjes J, Schmohl F, Waterham HR, Wanders RJ (2004b) Novel mutations in the PEX12 gene of patients with a peroxisome biogenesis disorder. Eur J Hum Genet 12:115–120
Gootjes J, Skovby F, Christensen E, Wanders RJ, Ferdinandusse S (2004c) Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorder. Neurology 62:2077–2081
Gould SJ, Raymond GV, Valle D (2001) The peroxisome biogenesis disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw–Hill, New York, pp 3181–3217
Hashimoto K, Kato Z, Nagase T, Shimozawa N, Kuwata K, Omoya K, Li A, Matsukuma E, Yamamoto Y, Ohnishi H, Tochio H, Shirakawa M, Suzuki Y, Wanders RJ, Kondo N (2005) Molecular mechanism of a temperature-sensitive phenotype in peroxisomal biogenesis disorder. Pediatr Res 58:263–269
Imamura A, Tamura S, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, Orii T, Kondo N, Osumi T, Fujiki Y (1998) Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. Hum Mol Genet 7:2089–2094
Korman SH, Mandel H, Gutman A (2000) Characteristic urine organic acid profile in peroxisomal biogenesis disorders. J Inherit Metab Dis 23:425–428
Mandel H, Espeel M, Roels F, Sofer N, Luder A, Iancu TC, Aizin A, Berant M, Wanders RJ, Schutgens RB (1994) A new type of peroxisomal disorder with variable expression in liver and fibroblasts. J Pediatr 125:549–555
Mandel H, Korman SH (2003) Phenotypic variability (heterogeneity) of peroxisomal disorders. Adv Exp Med Biol 544:9–30
Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D (1995) Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J Pediatr 127:13–22
Okumoto K, Abe I, Fujiki Y (2000) Molecular anatomy of the peroxin Pex12p: ring finger domain is essential for Pex12p function and interacts with the peroxisome-targeting signal type 1-receptor Pex5p and a ring peroxin, Pex10p. J Biol Chem 275:25700–25710
Osumi T, Imamura A, Tsukamoto T, Fujiwara C, Hashiguchi N, Shimozawa N, Suzuki Y, Kondo N (2000) Temperature sensitivity in peroxisome assembly processes characterizes milder forms of peroxisome biogenesis disorders. Cell Biochem Biophys 32:165–170
Poll-The BT, Gootjes J, Duran M, de Klerk JB, Wenniger-Prick LJ, Admiraal RJ, Waterham HR, Wanders RJ, Barth PG (2004) Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients. Am J Med Genet A 126:333–338
Raas-Rothschild A, Wanders RJ, Mooijer PA, Gootjes J, Waterham HR, Gutman A, Suzuki Y, Shimozawa N, Kondo N, Eshel G, Espeel M, Roels F, Korman SH (2002) A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents. Am J Hum Genet 70:1062–1068
Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, Valle D, Gould SJ (1997) Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet 17:445–448
Roels F, Saudubray JM, Giros M, Mandel H, Eyskens F, Saracibar N, Atares PB, Prats JM, De Prest B, De Preter K, Pineda M, Krystkowiak P, Gootjes J, Wanders RJ, Espeel M, Poll-The BT (2003) Peroxisome mosaics. Adv Exp Med Biol 544:97–106
Sacksteder KA, Jones JM, South ST, Li X, Liu Y, Gould SJ (2000) PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J Cell Biol 148:931–944
Schutgens RB, Schrakamp G, Wanders RJ, Heymans HS, Tager JM, van den BH (1989) Prenatal and perinatal diagnosis of peroxisomal disorders. J Inherit Metab Dis 12(Suppl 1):118–134
Steinberg S, Chen L, Wei L, Moser A, Moser H, Cutting G, Braverman N (2004) The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum. Mol Genet Metab 83:252–263
Steinberg S, Katsanis S, Moser A, Cutting G (2005) Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. J Med Genet 42:38–44
Valianpour F, Selhorst JJ, van Lint LE, van Gennip AH, Wanders RJ, Kemp S (2003) Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry. Mol Genet Metab 79:189–196
Vallance H, Applegarth D (1994) An improved method for quantification of very long chain fatty acids in plasma. Clin Biochem 27:183–186
Walter C, Gootjes J, Mooijer PA, Portsteffen H, Klein C, Waterham HR, Barth PG, Epplen JT, Kunau WH, Wanders RJ, Dodt G (2001) Disorders of peroxisome biogenesis due to mutations in PEX1: phenotypes and PEX1 protein levels. Am J Hum Genet 69:35–48
Wanders RJ (2004) Metabolic and molecular basis of peroxisomal disorders: a review. Am J Med Genet A 126:355–375
Wanders RJ, Dekker C, Ofman R, Schutgens RB, Mooijer P (1995a) Immunoblot analysis of peroxisomal proteins in liver and fibroblasts from patients. J Inherit Metab Dis 18(Suppl 1):101–112
Wanders RJ, Denis S, Ruiter JP, Schutgens RB, van Roermund CW, Jacobs BS (1995b) Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts. J Inherit Metab Dis 18(Suppl 1):113–124
Wanders RJ, Schutgens RB, van den Bosch H, Tager JM, Kleijer WJ (1991) Prenatal diagnosis of inborn errors in peroxisomal beta-oxidation. Prenat Diagn 11:253–261
Wanders RJ, van Roermund CW (1993) Studies on phytanic acid alpha-oxidation in rat liver and cultured human skin fibroblasts. Biochim Biophys Acta 1167:345–350
Wanders RJ, Waterham HR (2005) Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 67:107–133
Wanders RJ, Wiemer EA, Brul S, Schutgens RB, van den Bosch H, Tager JM (1989) Prenatal diagnosis of Zellweger syndrome by direct visualization of peroxisomes in chorionic villus fibroblasts by immunofluorescence microscopy. J Inherit Metab Dis 12 (Suppl 2):301–4
Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T, Fujiki Y, Osumi T, Hashimoto T, Moser HW (1992) Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Hum Genet 88:491–499
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeharia, A., Ebberink, M.S., Wanders, R.J.A. et al. A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 °C. J Hum Genet 52, 599–606 (2007). https://doi.org/10.1007/s10038-007-0157-y
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1007/s10038-007-0157-y
Keywords
This article is cited by
-
A founder mutation in PEX12 among Egyptian patients in peroxisomal biogenesis disorder
Neurological Sciences (2021)
-
Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity
Journal of Applied Genetics (2017)
-
Zellweger spectrum disorders: clinical overview and management approach
Orphanet Journal of Rare Diseases (2015)
-
Rational diagnostic strategy for Zellweger syndrome spectrum patients
European Journal of Human Genetics (2009)
